HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improved liver function and relieved pruritus after 4-phenylbutyrate therapy in a patient with progressive familial intrahepatic cholestasis type 2.

Abstract
To examine the effects of 4-phenylbutyrate (4PB) therapy in a patient with progressive familial intrahepatic cholestasis type 2. A homozygous c.3692G>A (p.R1231Q) mutation was identified in ABCB11. In vitro studies showed that this mutation decreased the cell-surface expression of bile salt export pump (BSEP), but not its transport activity, and that 4PB treatment partially restored the decreased expression of BSEP. Therapy with 4PB had no beneficial effect for 1 month at 200 mg/kg/day and the next month at 350 mg/kg/day but partially restored BSEP expression at the canalicular membrane and significantly improved liver tests and pruritus at a dosage of 500 mg/kg/day. We conclude that 4PB therapy would have a therapeutic effect in patients with progressive familial intrahepatic cholestasis type 2 who retain transport activity of BSEP per se.
AuthorsSotaro Naoi, Hisamitsu Hayashi, Takeshi Inoue, Ken Tanikawa, Koji Igarashi, Hironori Nagasaka, Masayoshi Kage, Hajime Takikawa, Yuichi Sugiyama, Ayano Inui, Toshiro Nagai, Hiroyuki Kusuhara
JournalThe Journal of pediatrics (J Pediatr) Vol. 164 Issue 5 Pg. 1219-1227.e3 (May 2014) ISSN: 1097-6833 [Electronic] United States
PMID24530123 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • ABCB11 protein, human
  • ATP Binding Cassette Transporter, Subfamily B, Member 11
  • ATP-Binding Cassette Transporters
  • Gastrointestinal Agents
  • Genetic Markers
  • Phenylbutyrates
  • 4-phenylbutyric acid
Topics
  • ATP Binding Cassette Transporter, Subfamily B, Member 11
  • ATP-Binding Cassette Transporters (genetics)
  • Cholestasis, Intrahepatic (complications, drug therapy, genetics)
  • Female
  • Gastrointestinal Agents (therapeutic use)
  • Genetic Markers
  • Homozygote
  • Humans
  • Infant
  • Liver Function Tests
  • Phenylbutyrates (therapeutic use)
  • Point Mutation
  • Pruritus (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: